AUPH - auriniapharma.com Bozor qiymatining balans qiymatiga nisbati
Nefritga qarshi dori vositasi uchun huquqlarining himoyasi va AQSh tibbiyoti doirasidagi kuchli ta'siri raqobatchilar uchun mustahkam to'siqni yaratadi, buni ushbu narxlar grafigi tasdiqlaydi, unda ko'rsatkich 3.70 darajasida turibdi. Aurinia Pharmaceuticals (AUPH) avtoimmun patologiyalar terapiyasi uchun klinikalarga Lupkynis yetkazib berish orqali daromad keltiradi. Biroq, portfelni kengaytirmasdan, faqatgina ushbu yagona mahsulotga to'liq bog'lanib qolish jiddiy moliyaviy xavflarni keltirib chiqaradi.
Aurinia Pharmaceuticals Inc (AUPH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Aurinia Pharmaceuticals|AUPH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Aurinia Pharma|AUPH - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Aurinia Pharma|AUPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Aurinia Pharmaceuticals|Tezkor likvidlik koeffitsiyenti auriniapharma.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Aurinia Pharmaceuticals - AUPH
Aurinia Pharmaceuticals (AUPH) sug'urta qamrovining kengayishi va lupus nefriti bilan kasallangan bemorlar bazasining o'sishi hisobiga tashqi zarbalarga past sezuvchanlikni namoyish etmoqda. Narxning buxgalteriya qiymatiga nisbati (P/B) tahlili orqali investorlar sof aktivlardan yuqori bo'lgan bozor narxi premiumini baholashlari mumkin, bu esa ularga kapitalning qayta baholanish yo'nalishini aniqlash va tendentsiya ortga qaytishidan oldin talab impulsini tutib olish imkonini beradi.
Raqobatchilar tahlili
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|biontech.de - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|BioCryst Pharmaceuticals Inc (BCRX) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Vera Corp|DNTH (Dianthus Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pharvaris.com|Kapitallashuvning sof aktivlarga nisbati ABCL (AbCellera Bio)|TRML (Tourmaline Bio Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PGEN (Intrexon)|Balans qiymatiga nisbatan bozor kapitallashuvi Pharming Corp (PHAR)|NKTR - Bozor qiymatining balans qiymatiga nisbati|upstreambio.com (UPB) - Kapitallashuvning sof aktivlarga nisbati|Zenas Biopharma (ZBIO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|Kapitallashuvning sof aktivlarga nisbati GOSS|Bozor kapitallashuvining balans qiymatiga nisbati KalVista Corp|Bozor qiymatining balans qiymatiga nisbati Septerna Inc (SEPN)|pieris.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SVRA (Savara)|Rigel Pharma (RIGL) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AnaptysBio Corp - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS - Bozor kapitallashuvining balans qiymatiga nisbati|ENGN (enGene Holdings Inc.) - Kapitallashuvning sof aktivlarga nisbati|rapt.com (RAPT) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Aerovate Therapeutics, Inc.|ACRS: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KYTX|Balans qiymatiga nisbatan bozor kapitallashuvi Tiziana Life Sciences, Ltd.|Bozor qiymatining balans qiymatiga nisbati Cabaletta Bio, Inc. CABA|VTYX: Kapitallashuvning balans qiymatiga nisbati|Theratechnologies - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Avalo Therapeutics, Inc. AVTX|ELDN: Bozor kapitallashuvining balans qiymatiga nisbati|Agenus, Inc (AGEN) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CLYM|ZURA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati aTyr Pharma (ATYR)|ADAG: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Balans qiymatiga nisbatan bozor qiymati STTK|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|CNTB - Bozor kapitallashuvining balans qiymatiga nisbati|immunic-therapeutics.com (IMUX) - Bozor qiymatining balans qiymatiga nisbati|Atara Bio - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati InflaRx NV|Kapitallashuvning sof aktivlarga nisbati X4 Pharmaceuticals, Inc (XFOR)|Bozor kapitallashuvining balans qiymatiga nisbati ACET|Bozor kapitallashuvining balans qiymatiga nisbati celularity.com (CELU)|Bozor kapitallashuvining balans qiymatiga nisbati INMB (INmune Bio)|BRNS - Kapitallashuvning sof aktivlarga nisbati|Kezar Life Sciences, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SAB Biotherapeutics Inc|AKTX (Akari Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Enlivex Therapeutics Ltd. (ENLV) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati QTTB|GOVX (GeoVax Labs) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|XTLB - Kapitallashuvning sof aktivlarga nisbati|Bolt Bio - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB - Bozor kapitallashuvining balans qiymatiga nisbati|aptevotherapeutics.com (APVO) - Bozor qiymatining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|gribio.com (GRI) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati Vyome Holdings Inc. (HIND)|Revelation Bio - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Indaptus Corp INDP|SCNI - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi CALI|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Allakos - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|IGM Bio - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|OCEA (oceanbiomedical.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD